EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Transcatheter tricuspid valve repair for tricuspid regurgitation: a meta-analysis of MitraClip, TriClip,and PASCAL Systems

Alina Abbas, Abdul Jabbar, Sajida Moiz Hussain Qamari, Hira Riaz

Global Cardiology · 01.07.2026 · 4 (2)

DOI: 10.4081/cardio.2026.104 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Global Cardiology, online erschienen am 01.07.2026. Verfasst von Alina Abbas und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tricuspid regurgitation (TR) is associated with significant morbidity and mortality, yet surgical intervention remains underutilized due to high operative risk. Transcatheter tricuspid valve repair (TTVr) has emerged as a less invasive alternative; however, comparative data across device platforms remain limited. We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines, searching PubMed/MEDLINE, Embase, and Cochrane Library up to March 2026. Studies evaluating TTVr using MitraClip, TriClip, or PASCAL in adults with moderate-to-severe TR were included. Primary outcomes included changes in TR severity and echocardiographic parameters (TR volume, vena contracta, effective regurgitant orifice area, tricuspid annular plane systolic excursion). Secondary outcomes included 6-minute walk distance (6MWD) and New York Heart Association (NYHA) functional class. A random-effects model was used for pooled analyses. Fifty studies were included in the meta-analysis. TTVr significantly reduced TR volume (MD −21.53 mL; 95% CI −24.72 to −18.35) and vena contracta (MD −5.91 mm; 95% CI −7.62 to −4.19), with consistent improvements across devices. Severe TR was significantly reduced (RR 0.32; 95% CI 0.26-0.39). Functional outcomes improved, with increased 6MWD (MD 36.14 m; 95% CI 23.85-48.43) and a higher proportion of patients achieving NYHA class I/II. A modest decline in TAPSE was observed (MD −0.74 mm). Subgroup analyses showed no significant differences in most echocardiographic outcomes, though functional improvements varied among devices. We concluded that TTVr is associated with significant improvements in TR severity, echocardiographic parameters, and functional status. Comparable outcomes across MitraClip, TriClip, and PASCAL suggest a potential class effect, supporting TTVr as an effective treatment option for high-risk patients.

Zitieren

APA

Abbas, A., Jabbar, A., Qamari, S. M. H., & Riaz, H. (2026). Transcatheter tricuspid valve repair for tricuspid regurgitation: a meta-analysis of MitraClip, TriClip,and PASCAL Systems. Global Cardiology, 4(2). https://doi.org/10.4081/cardio.2026.104

Vancouver

Abbas A, Jabbar A, Qamari SMH, Riaz H. Transcatheter tricuspid valve repair for tricuspid regurgitation: a meta-analysis of MitraClip, TriClip,and PASCAL Systems. Global Cardiology. 2026;4(2). doi:10.4081/cardio.2026.104

BibTeX
@article{Abbas2026,
  author = {Abbas, Alina and Jabbar, Abdul and Qamari, Sajida Moiz Hussain and Riaz, Hira},
  title = {Transcatheter tricuspid valve repair for tricuspid regurgitation: a meta-analysis of MitraClip, TriClip,and PASCAL Systems},
  journal = {Global Cardiology},
  year = {2026},
  volume = {4},
  number = {2},
  doi = {10.4081/cardio.2026.104}
}
Kostenlos starten →